Gamma-Glutamylcyclotransferase (GGCT) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Gamma-Glutamylcyclotransferase (GGCT) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityGamma-Glutamylcyclotransferase (GGCT)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpeptide affinity purified
Size80 µl, 400 µl,
Concentrationn/a
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionGGCT (EC 2.3.2.4) catalyzes the formation of 5-oxoproline (pyroglutamic acid) from gamma-glutamyl dipeptides and may play a significant role in glutathione homeostasis.
ImmunogenKLH-conjugated synthetic peptide between 139-168 amino acids from the C-terminal region of human GGCT.
Other NamesGGC, GCTG, CRF21, C7orf24, GGCT, Gamma-glutamylcyclotransferase, Cytochrome c-releasing factor 21, GGC, GGC, GGC , GGC , GCTG, GCTG, GCTG , GCTG , CRF21, CRF21, CRF21 , CRF21 , C7orf24, C7orf24, C7orf24 , C7orf24 , GGCT, GGCT, GGCT , GGCT , Gamma-glutamylcyclotransferase, Gamma-glutamylcyclotransferase, Gamma-glutamylcyclotransferase , Gamma-glutamylcyclotransferase , Cytochrome c-releasing factor 21, Cytochrome c-releasing factor 21, Cytochrome c-releasing factor 21 , Cytochrome c-releasing factor 21
Gene, Accession #GGCT, UniProt: O75223
Catalog #abx034467
Priceplease inquire
Order / More InfoGamma-Glutamylcyclotransferase (GGCT) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.